Disclosure under Regulation 29(2) of SEBI(SAST) Regulations, 2011 received from Ishita Pharmaceuticals, related party of Ishita Drugs and Industries Limited
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ishita Pharmaceuticals, a related party of Ishita Drugs & Industries Ltd, acquired 90 equity shares of Rs. 10 each via the open market on November 28, 2025. This raised its holding from 28,244 shares (0.94%) to 28,334 shares (0.95%) of the company. The total equity share capital of Ishita Drugs stands at Rs. 2.99 crore (29.90 lakh shares). The change in stake is extremely small, representing just 0.01% of the company's share capital.
This is a negligible acquisition (just 90 shares) by a related party and is unlikely to have any meaningful impact on the stock price or shareholder interests. It appears to be a routine compliance filing with no material consequence.